TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
INSM

Insmed Inc

Healthcare · Biotechnology

120.80$ -0.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow INSM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-560.1% -2,623.1% -183.7% -133.4% -192.8% -163.2% -175.7% -188.0% -154.2%
9.3% 49.1% 7.5% 8.6% 7.5% 4.2% 3.5% 3.0% 2.7%
98.5% 266.8% 19.8% 22.0% 24.4% 23.5% 24.5% 26.6% 25.2%
98.6% 289.3% 19.8% 22.0% 37.7% 18.9%
15.9% 160.0% -46.1% -1.8% -31.1% 2.7% -12.8% -0.9% -13.2%
46.5% 150.6% 31.0% 4.1% 3.9% 4.0% 4.4% 6.0% 5.4%
-46.4% -150.6% -31.0% -4.1% -34.1% -14.1% -73.3% -160.3% -10.6%
0.0%
960.0% 89.6% 205.7% 165.4% 154.9% 127.0%
40.7% 3,842.7% -0.7% -0.6% 170.7% 135.4% -0.4% 40.5% -0.8%
1,000.8% 3,932.3% 209.0% 164.8% 325.0% 323.3% 55.2% 368.7% 157.3%
394.2% 1,158.2% -5.6% 27.6% 97.6% 145.6% -193.9% 20.0% -7.4%
-606.7% -2,773.7% -214.6% -137.6% -196.6% -167.2% -180.1% -194.1% -159.6%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?